1. Home
  2. KROS vs NRGV Comparison

KROS vs NRGV Comparison

Compare KROS & NRGV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KROS
  • NRGV
  • Stock Information
  • Founded
  • KROS 2015
  • NRGV 2017
  • Country
  • KROS United States
  • NRGV United States
  • Employees
  • KROS N/A
  • NRGV N/A
  • Industry
  • KROS Biotechnology: Pharmaceutical Preparations
  • NRGV Industrial Machinery/Components
  • Sector
  • KROS Health Care
  • NRGV Miscellaneous
  • Exchange
  • KROS Nasdaq
  • NRGV Nasdaq
  • Market Cap
  • KROS 565.0M
  • NRGV 514.7M
  • IPO Year
  • KROS 2020
  • NRGV N/A
  • Fundamental
  • Price
  • KROS $15.91
  • NRGV $3.77
  • Analyst Decision
  • KROS Buy
  • NRGV Buy
  • Analyst Count
  • KROS 14
  • NRGV 3
  • Target Price
  • KROS $20.56
  • NRGV $1.83
  • AVG Volume (30 Days)
  • KROS 424.2K
  • NRGV 4.0M
  • Earning Date
  • KROS 11-05-2025
  • NRGV 11-11-2025
  • Dividend Yield
  • KROS N/A
  • NRGV N/A
  • EPS Growth
  • KROS N/A
  • NRGV N/A
  • EPS
  • KROS 0.47
  • NRGV N/A
  • Revenue
  • KROS $232,844,000.00
  • NRGV $51,716,000.00
  • Revenue This Year
  • KROS $6,657.47
  • NRGV $314.58
  • Revenue Next Year
  • KROS N/A
  • NRGV $39.00
  • P/E Ratio
  • KROS $34.14
  • NRGV N/A
  • Revenue Growth
  • KROS 85820.30
  • NRGV N/A
  • 52 Week Low
  • KROS $9.12
  • NRGV $0.60
  • 52 Week High
  • KROS $72.37
  • NRGV $3.79
  • Technical
  • Relative Strength Index (RSI)
  • KROS 54.08
  • NRGV 78.27
  • Support Level
  • KROS $15.50
  • NRGV $3.29
  • Resistance Level
  • KROS $16.44
  • NRGV $3.75
  • Average True Range (ATR)
  • KROS 0.57
  • NRGV 0.35
  • MACD
  • KROS -0.01
  • NRGV -0.00
  • Stochastic Oscillator
  • KROS 59.87
  • NRGV 95.91

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

About NRGV Energy Vault Holdings Inc.

Energy Vault Holdings Inc is a grid-scale energy storage company that is driving a faster transition to renewable power by solving the intermittence issues that are inherent to the prevalent sources of renewable energy, solar and wind. Geographical presence in United States, China and Other. Majority of its revenue comes from U.S.

Share on Social Networks: